Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fufang E'Jiao Jiang for Cancer-Related Fatigue
NCT04147312Unknown
- Sponsor
- Xiyuan Hospital
- Start
- Oct 2019
- Primary completion
- May 2021
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of Fufang E'jiao Jiang in cancer-related fatigue (CRF) (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Fatigue degree with the Piper fatigue scale (Piper) at 6 weeks. Status: unknown.
02
Drugs
Fufang E'jiao Jiang
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT04147312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147312.